Follicular thyroid cancer incidence patterns in the United States, 1980-2009.

BACKGROUND The increases in thyroid cancer overall and in the predominant papillary type have been well documented, but trends for follicular thyroid cancer, a less common but more aggressive variant, have not been as well characterized. In this study, we determined the incidence patterns for follicular thyroid cancer and compared trends between the follicular and papillary thyroid cancers in the United States. METHODS We used the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program to examine incidence in the United States during 1980-2009, stratified by demographic and tumor characteristics. Incidence rates (IR) were calculated, relative risks were expressed as incidence rate ratios (IRR), and temporal trends were expressed as percentage changes and plotted. RESULTS Overall we observed a modest increase in age-adjusted follicular thyroid cancer rates among women (31.89%) and men (35.88%). Rates increased most dramatically for regional stage tumors compared to localized tumors in women, whereas the rates for all tumor sizes rose. These findings reveal increases in more aggressive tumors in women in addition to small and localized tumors. The trends for males were different from those among females. Among males, the largest increase was observed for regional and smaller size tumors. The papillary-to-follicular IRR overall was 7.07 [95% confidence interval 6.91-7.24], which varied from 7.37 among Whites to 3.86 among Blacks (SEER race/ethnicity categories), and increased significantly from 3.98 during 1980-1984 to 9.88 during 2005-2009. CONCLUSION The different trends for follicular and papillary types of thyroid cancer illustrate that thyroid cancer is a heterogeneous disease. Our results do not support the hypothesis that increasing thyroid cancer rates are largely due to improvements in detection, and suggest the importance of evaluating thyroid cancer types separately in future studies.

[1]  R. D. Lloyd,et al.  A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. , 1993, JAMA.

[2]  P. Rosenberg,et al.  Gender is an Age-Specific Effect Modifier for Papillary Cancers of the Thyroid Gland , 2009, Cancer Epidemiology Biomarkers & Prevention.

[3]  D. Stockton,et al.  Changing trends in incidence and mortality of thyroid cancer in Scotland , 2005, Clinical endocrinology.

[4]  J. Ferlay,et al.  Histological groups. , 2014, IARC scientific publications.

[5]  Shuangge Ma,et al.  A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. , 2009, Thyroid : official journal of the American Thyroid Association.

[6]  O. Clark,et al.  The Evolution of Biomarkers in Thyroid Cancer—From Mass Screening to a Personalized Biosignature , 2010, Cancers.

[7]  Y. Nikiforov.  Radiation-induced thyroid cancer: What we have learned from Chernobyl , 2006, Endocrine pathology.

[8]  A. Ugnat,et al.  Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects , 2001, British Journal of Cancer.

[9]  S. Devesa,et al.  Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. , 2011, Thyroid : official journal of the American Thyroid Association.

[10]  P. Sparén,et al.  Is residence in areas of endemic goiter a risk factor for thyroid cancer? , 1995, International journal of cancer.

[11]  Robert L. Jones,et al.  Iodine status of the U.S. population, National Health and Nutrition Examination Survey 2003-2004. , 2008, Thyroid : official journal of the American Thyroid Association.

[12]  Chr. Hedinger,et al.  Histological Typing of Thyroid Tumours , 1988, World Health Organization.

[13]  K. Rahbar,et al.  Risk-profile and outcome of small papillary and follicular thyroid carcinomas (≤1 cm) , 2008, Nuklearmedizin.

[14]  R. Zarnegar,et al.  Bone metastases from differentiated thyroid carcinoma. , 2008, Endocrine-related cancer.

[15]  P DESAIVE,et al.  [Thyroid cancer]. , 1951, Revue medicale de Liege.

[16]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[17]  D. Henson,et al.  Changing Patterns in the Incidence and Survival of Thyroid Cancer with Follicular Phenotype—Papillary, Follicular, and Anaplastic: A Morphological and Epidemiological Study , 2007, Endocrine pathology.

[18]  P. Dasgupta,et al.  Iodine nutrition: iodine content of iodized salt in the United States. , 2008, Environmental science & technology.

[19]  Nathaniel Rothman,et al.  International patterns and trends in thyroid cancer incidence, 1973–2002 , 2009, Cancer Causes & Control.

[20]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[21]  S. Devesa,et al.  Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005 , 2009, Cancer Epidemiology Biomarkers & Prevention.

[22]  E. Hindié,et al.  Update on the diagnosis and therapy of distant metastases of differentiated thyroid carcinoma. , 2008, Minerva endocrinologica.